1Jacoby GA. Extended-spectrum β-lactamases and other enzymes providing resist ance to oxyimino-β-lactams[J]. Infect Dis Clin North Am, 1997, 11: 875 -887
2Stobberingh EE, Arends J, Hoogkamp-Korstanje JA, et al. Occurrence of exten ded-spectrum β-lactamas in Dutch Hospitals[J]. Infection, 1999, 27: 348 -354
3Yagi T, Kurokawa H, Shibata N, et al. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Esch erichia coli in Japan[J]. FEMS Microbiol Lett, 2000, 184: 53-56
4Bradford PA. Extended-Spectrum β-Lactamases in the 21st Centu ry: characteriza tion, epidemiology, and detection of this important resistance threat[J]. Clin Microbiol Rev, 2001, 14: 933-951
5Rosenau A, Cattier B, Gousset N, et al. Capnocytophaga ochracea: characterization of a plasmid encoded-extended-spectrum TEM-17 β-lactamase in the phylu m F lavobacter-Bacteroides[J]. Antimicrob Agents Chemother, 2000, 44: 760-762
6Huletsky A, Knox JR, Levesque RC. Role of Ser-238 and Lys-240 in the hydrolys is of third-generation cephalosporins by SHV-type β-lactamas probed by s ite-directed mutagenesis and 3-dimensional modeling[J]. J Biol Chem, 1993, 268: 3 690-3697
7Yuan M, Hall LM, Hoogkamp-Korstanje J, et al. SHV-14, a novelbeta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands[J]. A ntimicrob Agents Chemother, 2001, 45:309-311
8Chang FY, Siu LK, Fung CP, et al. Diversity of SHV and TEM beta -lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-la c tamases, SHV-25 and SHV-26[J]. Antimicrob Agents Chemother, 2001, 45: 240 7-2413
1Poirel L,Heritier C,Tolun V,etal. Emergence of oxacillinase- mediated resistance to imipenem in Klebsilla pneumoniae [J]. Antimierob Agents Chemother, 2004,48( 1 ) : 15 -22.
2Jan W R, Niels H. OXA-type carbapenemases [J]. J Antimicrob Chemother,2006,57(3) :373 - 383.
3Danel F, Hall L M, Livermore D M. Laboratory mutants of OXA-10 β-laetamase giving ceftazidime resistance in Pseudomonas aeruginosa [J]. J Antimicrob Chemother, 1999,43(3) : 339 - 344.
4Weldhagen G,Poirel L, Nordmann P. Ambler class A extend ed spectrum beta lactamases in Pseudomonas aeruginosa : novel developments and clinical impact [J]. Antimicrob Agents Chemother,2003,47(8) :2385 - 2392.
5Boo T W, Walsh F, Crowley B. First report of OXA~23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic [J]. J Antimicrob Chemother, 2006,58(5):1101 - 1102.
6Siu L K, Lo J Y, Yuen K Y, et al.β-lactamases in Shigella flexneri solates from Hong Kong and Shanghai and a Novel OXA-l-like ~-lactamase, OXA-30 [ J ]. Antimicrob Agents Chemother,2000,44(8) :2034 -2038.
7Hail L M,Livermore D M, Gur D, et al. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta lactamase from Pseudomonasaeruginosa [J]. Antimicrob Agents Chemother, 1993,37(8) : 1637 - 1644.
8Danel F, Hall L M ,Gur D,et al. OXA-16, a further extended spectrum variant of OXA10 β-lactamase, from two Pseud- omonas aeruginosa isolates [J]. Antimicrob Agents Chemother, 1998,42(12):3117 - 3122.
9Danel F, Hall L M ,Gur D,etal. OXA-17, a further extended spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 1999,43(6) : 1362 - 1366.
10Scoulica E,Aransay A,Tselentis Y. Molecular characterization of the OXA-7 β-lactamase gene [J]. Antimicrob Agents Chemother, 1995,39(6) :1379 - 1382.
